INN CEO Talks: BioHarvest Sciences CEO Ilan Sobel

TL;DR

Bioharvest Sciences has reached a critical milestone in the production of cannabis trichomes in liquid media, enabling consistent growth and optimization. They are focused on bringing a new grade of cannabis to the market with fingerprint consistency, sustainability, and cost efficiency.

Transcript

welcome to another edition of inn's ceo talks joining me today is elon sobel of bioharvest sciences which trades on the cse under the symbol bhsc and on the otc under the symbol cnvcf this is elon's second appearance on the show we first met in the summer of 2020 shortly after bio harvest and canada v cell merged and ellen was appointed to the role... Read More

Key Insights

• 💗 Bioharvest Sciences has achieved a significant milestone in growing cannabis trichomes in liquid media with consistency.
• 🇨🇷 The technology offers fingerprint consistency, sustainability, and cost efficiency in the production of cannabis and cannabinoids.
• 🚙 Focus on human utility value, sustainability, and purpose drives the company's strategy.
• ❓ The technology has the potential to address concerns about quality and dosage in the pharmaceutical industry.
• 🌱 Bioharvest Sciences plans to scale its production and expand into various markets.
• ❓ The company also operates in the superfruit nutraceutical market with its vineyard product.
• 🧑‍⚕️ Investors have the opportunity to join the company's purpose-driven journey and contribute to improving global health and wellness.

Questions & Answers

Q: What is the significance of Bioharvest Sciences' achievement in growing cannabis trichomes in liquid media?

This achievement is significant because it allows for consistent and optimized growth of trichomes, which are responsible for producing the beneficial compounds in cannabis. It enables large-scale production of plant-based cannabis products with fingerprint consistency and cost efficiency.

Q: How does Bioharvest Sciences' technology ensure consistency in the growth of trichomes?

Bioharvest Sciences uses its proprietary biofarming technology to create a cell bank for each strain of cannabis. This allows them to control and reproduce the growth conditions, ensuring consistent trichome production and maintaining the desired composition of cannabinoids, turpenes, and flavonoids.

Q: What advantages does Bioharvest Sciences' technology offer in terms of sustainability?

By growing cannabis trichomes in liquid media, Bioharvest Sciences reduces the carbon footprint associated with traditional plant cultivation methods. They also have a low cost of capital, making their production process more economically sustainable.

Q: Which markets will Bioharvest Sciences initially focus on?

The company plans to initially focus on the medicinal and farmer markets, given the constraints on capacity. As capacity increases, they will expand into other opportunities such as the recreational market. They are targeting North America, starting with Israel and then moving into the US and Canada.

Summary & Key Takeaways

• Bioharvest Sciences has successfully developed a proprietary technology to grow cannabis trichomes in liquid media with optimization and consistency.

• The trichomes are responsible for producing cannabinoids, turpenes, and flavonoids in the cannabis plant.

• This achievement allows Bioharvest Sciences to commercialize large-scale manufacturing of plant-based cannabis and cannabinoids.